PATH’s Advocacy and Policy program ensures that policymakers, advocates, and citizens around the world have the resources and information to make evidence-based decisions that will improve the health of women and children.
PATH and our partners work to increase use of lifesaving tools in countries where the burden of malaria is high and to develop new strategies and tools that can help countries with low levels of malaria transmission stop the disease altogether.
PATH’s Center for Vaccine Innovation and Access brings together our expertise across every stage of vaccine research, development, and introduction to make lifesaving vaccines widely available to women, children, and communities around the world.
PATH’s Diagnostics program advances point-of-care tools and technologies designed specifically for use in low-resource areas, creating solutions that enable health innovations to reach communities throughout the world who most need them.
PATH’s Digital Health Solutions program is working to drive better use of better data to improve health care systems at every level by supporting countries in the development and implementation of sustainable digital solutions.
PATH’s Drug Development program develops and advances safe and effective medicines that prevent and treat diseases that disproportionately affect women and children in low-resource settings, including enteric and diarrheal diseases, neglected tropical diseases, and HIV.
PATH’s Global Health Security Partnership helps countries strengthen their health systems by expanding infectious disease surveillance, strengthening laboratory capacity, and developing effective information systems.
PATH advances a range of affordable and accessible health technologies to improve the health of women and children, from noninvasive methods to detect anemia to devices for safe childbirth and infant feeding when nursing isn’t an option.
PATH’s HIV/AIDS and Tuberculosis program takes a multifaceted approach to address the broad spectrum of clinical, social, and structural issues that fuel these intertwined epidemics by strengthening health systems and helping local partners take the lead in designing, implementing, and scaling up successful service delivery interventions and innovations.
PATH’s Kenya program works closely with Kenya’s leaders, communities, and decision-makers at the local and national levels to implement sustainable health solutions across the areas of HIV and tuberculosis, malaria, women’s and children’s health, and noncommunicable diseases.
PATH’s Market Development Toolkit offers practical guidance, working models, case studies, and tools to organizations that wish to use commercial approaches for social good.
PATH works to strengthen markets to meet critical health needs, addressing the five A’s of an effectively functioning market for a health product: affordability, availability, assured quality, appropriate design, and awareness.
PATH’s Maternal, Newborn, and Child Health and Nutrition program focuses on affordable, appropriate, and sustainable solutions for improved health and better nutrition for mothers and their children in hard-to-reach communities.
PATH’s Myanmar country program partners with government, businesses, and civil society organizations to improve nutrition, increase immunization coverage, support women’s reproductive health, and strengthen health care waste management systems.
PATH’s work to increase access to oxygen therapy for newborns, children, and pregnant women through normative policy change includes providing advocates with the HO2PE campaign kit, evidence-based resources, and World Health Organization guidelines.
PATH’s Reproductive Health program works with public health professionals, communities, and country-level leadership to ensure that women everywhere, regardless of age, marital status, or wealth, can access the sexual and reproductive health information and services they need to stay healthy.
PATH’s Senegal country program has a broad portfolio, with focus areas ranging from strengthening health systems and epidemic preparedness to malaria, reproductive health, and noncommunicable diseases.
PATH’s South Africa country program collaborates with partners across sectors to improve health for women and children, help those most affected by HIV, and advance innovative technologies designed for resource-limited communities.
PATH’s work in reproductive health technologies engages with users and partners in the public and private sectors to develop and introduce innovative, culturally appropriate technologies for women and men that expand options for contraception and protection from sexually transmitted infections.
PATH’s Technology Solutions program collaborates with multisector partners to advance appropriate technology solutions for the health needs of people living in low-resource settings.
PATH’s work in delivery technologies includes vaccine technologies that eliminate needles; low-cost packaging options that reduce waste; and novel delivery routes and methods that increase acceptability and improve vaccine and drug efficacy.
PATH’s work in formulation and stabilization technologies focuses on inventing, adapting, testing, and validating emerging concepts, formulation technologies, and product formats that optimize vaccine and pharmaceutical efficacy, stability, safety, and ease of use in low-resource settings.
PATH’s work in supply systems and equipment ensures the safe and effective management and distribution of vaccines and essential medicines in low-resource settings, especially as new products are introduced into already over-burdened national supply chains.
PATH’s work in vaccine and pharmaceutical technologies extends across three interrelated yet thematically unique technical portfolios: delivery technologies; formulation and stabilization technologies; and supply systems and equipment.
PATH’s Vietnam country program collaborates across sectors to build greater preparedness for public health threats, increase immunization coverage, and introduce innovation to address long-standing infectious diseases such as HIV and the rising burden of noncommunicable diseases like hypertension.
PATH’s WASH portfolio, in collaboration with our multisector partners, develops, evaluates, and introduces technologies in the areas of safe water, improved sanitation, fecal sludge management, clean air, hygiene, and menstrual health.
Banner photo: PATH/Aurelio Ayala III.